Campus to Nasdaq: Building a MedTech Leader Transforming Brain Care

We are delighted to introduce Jane Chao, PhD ’05, Cornell alum and co-founder and CEO of Ceribell. Ceribell is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions.

Jane is an outstanding leader who successfully took Ceribell public in 2024 and has continued to deliver strong performance for shareholders. More importantly, Ceribell’s products provide lifesaving critical care for patients with non-convulsive seizures and real-time bedside monitoring for patients with delirium, addressing important and often overlooked challenges in the ICU.

Please join us for “Campus to Nasdaq: Building a MedTech Leader Transforming Brain Care,” where Jane will share her journey from Cornell researcher to medtech entrepreneur and CEO, the problem Ceribell is tackling, and how her PhD training helped shape her career.

This free event is a great fit for life sciences researchers and students interested in entrepreneurship.